Tine M Søland1,2, Inger-Heidi Bjerkli3,4, Jeanette B Georgsen5, Olaf Schreurs1, Peter Jebsen2, Helene Laurvik2, Dipak Sapkota1. 1. Faculty of Dentistry, Institute of Oral Biology, University of Oslo, Oslo, Norway. 2. Department of Pathology, Rikshospitalet, Oslo University Hospital, Oslo, Norway. 3. Department of Otorhinolaryngology, University Hospital of North Norway, Tromsø, Norway. 4. Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway. 5. Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Abstract
OBJECTIVES: The presence of and the causative role of high-risk human papilloma virus (HPV) is a subject of controversy in oral squamous cell carcinoma (OSCC). The disagreement can be related to the misclassification of OSCC as oropharyngeal squamous cell carcinoma and/or lack of standard detection methods. This study aimed to examine the presence of transcriptionally active high-risk HPV in a homogenous Norwegian cohort of primary and second primary OSCC of the mobile tongue (oral tongue squamous cell carcinoma-OTSCC). METHODS: Tissue microarrays containing formalin-fixed and paraffin-embedded cores of 146 OTSCC from the anterior 2/3 of the tongue (n = 128 primary and n = 18 second primary) from a multicentric Norwegian cohort were examined for the presence of high-risk HPV by DNA- and RNA-in situ hybridization (ISH) assays and p16 immunohistochemistry. RESULTS: Transcriptionally active HPV (E6/E7 mRNA) was not identified in any of the OTSCC specimens. In parallel, no tumors were positive for HPV by DNA ISH. Although, 61 (42%) OTSCC demonstrated p16 positivity with varying staining intensity and subcellular localization, only two cases demonstrated strong and uniform p16-staining (both cytoplasmic and nuclear) in >70% of cancer cells. The absence of transcriptionally active high-risk HPV in this cohort of OTSCC indicates that high-risk HPV is an unlikely causative factor in the present material.
OBJECTIVES: The presence of and the causative role of high-risk human papilloma virus (HPV) is a subject of controversy in oral squamous cell carcinoma (OSCC). The disagreement can be related to the misclassification of OSCC as oropharyngeal squamous cell carcinoma and/or lack of standard detection methods. This study aimed to examine the presence of transcriptionally active high-risk HPV in a homogenous Norwegian cohort of primary and second primary OSCC of the mobile tongue (oral tongue squamous cell carcinoma-OTSCC). METHODS: Tissue microarrays containing formalin-fixed and paraffin-embedded cores of 146 OTSCC from the anterior 2/3 of the tongue (n = 128 primary and n = 18 second primary) from a multicentric Norwegian cohort were examined for the presence of high-risk HPV by DNA- and RNA-in situ hybridization (ISH) assays and p16 immunohistochemistry. RESULTS: Transcriptionally active HPV (E6/E7 mRNA) was not identified in any of the OTSCC specimens. In parallel, no tumors were positive for HPV by DNA ISH. Although, 61 (42%) OTSCC demonstrated p16 positivity with varying staining intensity and subcellular localization, only two cases demonstrated strong and uniform p16-staining (both cytoplasmic and nuclear) in >70% of cancer cells. The absence of transcriptionally active high-risk HPV in this cohort of OTSCC indicates that high-risk HPV is an unlikely causative factor in the present material.
Authors: K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison Journal: N Engl J Med Date: 2010-06-07 Impact factor: 91.245
Authors: Reija Randén-Brady; Timo Carpén; Lauri Jouhi; Stina Syrjänen; Caj Haglund; Jussi Tarkkanen; Satu Remes; Antti Mäkitie; Petri S Mattila; Suvi Silén; Jaana Hagström Journal: Hum Pathol Date: 2019-05-21 Impact factor: 3.466
Authors: Boudewijn J M Braakhuis; Ruud H Brakenhoff; Chris J L M Meijer; Peter J F Snijders; C René Leemans Journal: Eur J Cancer Date: 2009-09-18 Impact factor: 9.162
Authors: Inger-Heidi Bjerkli; Olav Jetlund; Gunnhild Karevold; Ása Karlsdóttir; Ellen Jaatun; Lars Uhlin-Hansen; Oddveig G Rikardsen; Elin Hadler-Olsen; Sonja E Steigen Journal: PLoS One Date: 2020-01-16 Impact factor: 3.240
Authors: Marta Tagliabue; Pietro Belloni; Rita De Berardinis; Sara Gandini; Francesco Chu; Stefano Zorzi; Caterina Fumagalli; Luigi Santoro; Susanna Chiocca; Mohssen Ansarin Journal: Cancer Med Date: 2021-03-24 Impact factor: 4.452
Authors: Tine M Søland; Inger-Heidi Bjerkli; Jeanette B Georgsen; Olaf Schreurs; Peter Jebsen; Helene Laurvik; Dipak Sapkota Journal: Clin Exp Dent Res Date: 2020-11-03